Top 5 Integrated Utility Companies To Buy For 2015

With shares of Dell (NASDAQ:DELL) trading around $13, is DELL an OUTPERFORM, WAIT AND SEE, or STAY AWAY? Let�� analyze the stock with the relevant sections of our CHEAT SHEET investing framework:

T = Trends for a Stock’s Movement

Dell is a global information technology company that offers its customers a range of solutions and services, which are delivered directly by Dell as well as other distribution channels. The company operates in four segments: Large Enterprise, Public, Small and Medium Business, and Consumer. Dell serves a wide range of customers: global and national corporate businesses; educational institutions; government, health care, and law enforcement agencies; small and medium-sized businesses; as well as end users. Through its four segments, Dell is able to provide information technology products to a growing user base around the world.

Dell is set to finally land in the arms of founder Michael Dell. A shareholder vote on Thursday is expected to approve Michael Dell�� $25 billion offer to take the PC maker private. Michael Dell had been in a bidding war with activist investor Carl Icahn for months, but earlier this week, Icahn dropped out of the race. Michael Dell partnered with Silver Lake Management to finance the deal.

Top 5 Integrated Utility Companies To Buy For 2015: Tortoise Pipeline & Energy Fund Inc (TTP)

Tortoise Pipeline & Energy Fund, Inc. (the Fund) is a non-diversified, closed-end management investment company. The Fund�� investment objective is to provide a high level of total return. It focuses to provide stockholders a vehicle to invest in a portfolio consisting of equity securities of pipeline and other energy infrastructure companies. It focuses on pipeline companies, which are engaged in the business of transporting natural gas, natural gas liquids (NGLs), crude oil and refined petroleum products, and on other energy infrastructure companies. It focus invest at least 80% of its total assets in equity securities of pipeline and other energy infrastructure companies. It may invest up to 30% of its total assets in unregistered or otherwise restricted securities, primarily through direct investments in securities of listed companies. Tortoise Capital Advisors, L.L.C. serves as the Fund�� investment adviser. Advisors' Opinion:

• [By Robert Rapier]

  As I write this, Tortoise Pipeline and Energy (NYSE: TTP) trades at a discount of 15.1 percent to its underlying assets, while at the other end of the spectrum Cushing MLP Total Return Fund (NYSE: SRV) trades at a 17.4 percent premium. The average MLP closed-end fund listed trades at a 4.9 percent discount, which is perhaps reasonable given the loss of certain tax advantages and the fact that management fees will eat into returns.

Top 5 Integrated Utility Companies To Buy For 2015: Prana Biotechnology Ltd (PRAN)

Prana Biotechnology Limited engages in the research and development of therapeutic drugs for the treatment of neurological disorders in Australia. The company primarily focuses on the Alzheimer�s, Parkinson�s, and Huntington�s diseases, as well as various cancer, age-related macular degeneration and cataract, Motor Neuron, and Creutzfeldt-Jakob diseases. Its development stage product line comprises PBT2, a Phase IIb clinical trial product for the treatment of Alzheimer�s disease; and PBT2, a Phase IIa clinical trial product for the treatment of Huntington�s disease. The company was formerly known as Prana Corporation Ltd. and changed its name to Prana Biotechnology Limited in January 2000. Prana Biotechnology Limited was founded in 1997 and is based in Parkville, Australia.

Advisors' Opinion:

• [By James Brumley]

  SGNT stock is also valued at a palatable trailing P/E of 19.8, and has logged six straight quarterly earnings beats, making it one of the best cheap stocks in the pharmaceutical industry.

  Prana Biotechnology (PRAN)

  It’s a slippery slope when you start placing bets based on a company with no marketable product, and a lead candidate that’s only in Phase 2 trials. But, Prana Biotechnology (PRAN) may be one of those cheap stocks within the drugmaking world that’s worth the risk.

• [By Bryan Murphy]

  Considering Eli Lilly & Co. (NYSE:LLY) as well as a co-development project between Johnson & Johnson (NYSE:JNJ) and Pfizer Inc. (NYSE:PFE) both failed in semi-recent effort to develop a similar-functioning Alzheimer's drug, it would be easy to assume that particular route towards an Alzheimer's might be the wrong path to take. Sometimes though, a small tweak or a seemingly-minor nuance with the underlying problem can make all the difference. Enter Prana Biotechnology Limited (NASDAQ:PRAN). Though the company acknowledges its focal point on the development of an Alzheimer's therapy is the same broad premise that ultimately led LLY, PFE, and JNJ to failure, PRAN may have found the proverbial missing link.

• [By John Udovich]

  The biotech sector has been pretty exciting this year�with small cap biotech stocks Prana Biotechnology Limited (NASDAQ: PRAN) and TNI BioTech (OTCMKTS: TNIB) having recently produced noteworthy news for investors�while Acceleron Pharma, Inc (NASDAQ: XLRN), Ophthotech (NASDAQ: OPHT) and BIND Therapeutics (NASDAQ: BIND) have just�set term sheets for their upcoming IPOs. Just consider all of the following recent news:

Hot Companies To Buy Right Now: Wet Seal Inc (WTSL)

The Wet Seal, Inc., incorporated in 1990, is a specialty retailer operating stores selling apparel and accessory items designed for female customers aged 15 to 39 years old. As of January 28, 2012, the Company operated 558 retail stores in 47 states and Puerto Rico. Its products can also be purchased online through its Websites. It operates two nationwide, primarily mall-based, chains of retail stores under the names Wet Seal and Arden B. Wet Seal is a junior apparel brand for teenage girls who seek trend-focused clothing, with a target customer age range of 15 to 23 years old. Arden B is a fashion brand for the feminine contemporary woman. Arden B targets customers aged 25 to 39 years old and seeks to deliver collections of fashion and basic separates and accessories for various aspects of the customers��lifestyles. During fiscal year ended January 28, 2012 (fiscal 2011), the Company opened 28 and closed six Wet Seal stores and opened four and closed one Arden B stores.

The Company maintains a Web-based store located at www.wetseal.com, offering Wet Seal merchandise comparable to that carried in its stores, to customers over the Internet. The Company also maintains a Web-based store located at www.ardenb.com, offering Arden B merchandise comparable to that carried in its stores, to customers over the Internet. Its online stores are designed to serve as an extension of the in-store experience and offer a range of merchandise. Wet Seal stores average approximately 4,000 square feet in size. As of January 28, 2012, the Company operated 472 Wet Seal stores and Arden B stores average approximately 3,100 square feet in size.

The Company competes with Abercrombie & Fitch, Aeropostale, American Eagle, Anthropologie, Banana Republic, BCBG, bebe, Body Central, Charlotte Russe, Express, Forever 21, Gap, Guess?, H&M, Nordstrom, Old Navy, Pacific Sunwear, Rue 21, Target, Urban Outfitters and Zara. As of April 28, 2012, the Company operated a total of 553 stores in 47 states and Puerto! Rico, including 469 Wet Seal stores and 84 Arden B stores.

Advisors' Opinion:

• [By WWW.DAILYFINANCE.COM]
  Records fell on Wall Street Friday as another solid report on housing lifted the market for the second day in a row. There's a three-day weekend coming up -- something that often prompts investor caution -- but the gains were broad-based even though volume was fairly light. The VIX, which measures volatility, fell to its lowest level this year. The Dow Jones industrial average (^DJI) gained 63 points, the Nasdaq composite (^IXIC) rose 31, and the Standard & Poor's 500 index (^GPSC) added 8, topping the record high set last week. The Dow Transportation average also raced to an all-time high, lifted by airline stocks. United (UAL) soared more than 4 percent; Delta (DAL) gained more than 1 percent and Southwest (LUV) gained 2 percent. Southwest is at an all-time high, up 79 percent from a year ago. New home sales bounced back with a better than expected 6.4 percent increase last month. Lennar (LEN) and D.R. Horton (DHI) both rose 4 percent. Pulte (PHM), Beazer (BZH) and Hovnanian (HOV) also solid posted gains. Earnings continue to drive retail stocks. Gap (GPS) edged higher even though net fell. Foot Locker (FL) gained 1½ percent after topping expectations. GameStop (GME) rose 4 percent. Its net rose, helped by the rollout last year of new Xbox and PlayStation consoles. Zumiez (ZUMZ) rose 5½ percent on an earnings beat. But Aeropostale (ARO) tumbled 24 percent. Its loss widened and sales declined. The retailer continues to struggle with teen fashion trends. Also on the earnings front, TiVo (TIVO) rose 2 percent as it swung to a profit from a year ago loss. It also reported an increase in the number of subscribers. Hewlett-Packard (HPQ) rose 6 percent on news the company plans to eliminate up to 16,000 additional workers in an effort to cut costs. And several stocks extended big moves from yesterday. Best Buy (BBY) rose more than 3 percent for the second straight day after earnings beat expectations. Isis Pharmaceuticals (ISIS) jumped
• [By Seth Jayson]

  Wet Seal (Nasdaq: WTSL  ) reported earnings on May 28. Here are the numbers you need to know.

  The 10-second takeaway
  For the quarter ended May 4 (Q1), Wet Seal met expectations on revenues and met expectations on earnings per share.

• [By Ben Levisohn]

  Shares of Abercrombie & Fitch have gained 11% to $36.78 today, even as Aeropostale (ARO) has dropped 5.2% to $8.50, and Zumiez (ZUMZ) has fallen 5.6% to $22.85. Wet Seal (WTSL), meanwhile, has gained 0.8% to $2.60 and�American Eagle Outfitters (AEO) has advanced 0.9% to %15.46.

• [By Caroline Chen]

  CEOs were replaced at Canadian Pacific Railway Ltd. (CP) and Procter & Gamble Co. (PG) after activist investor Bill Ackman pushed for shakeups. Greg Taxin�� Clinton Group Inc. prompted management changes at Nutrisystem Inc. (NTRI) and Wet Seal Inc. (WTSL) in the past year.

Top 5 Integrated Utility Companies To Buy For 2015: BIND Therapeutics Inc (BIND)

BIND Therapeutics, Inc., incorporated on May 19, 2006, is a clinical-stage nanomedicine platform company developing Accurins, its targeted and programmable therapeutics. Accurins are designed with specified physical and chemical characteristics to target specific cells or tissues and concentrate a therapeutic payload at the site of disease to enhance efficacy while minimizing adverse effects on healthy tissues. Its drug candidate, BIND-014, is in Phase II clinical trials for non-small cell lung cancer, or NSCLC, and metastatic castrate-resistant prostate cancer (mCRPC).

Accurins represent the evolution of targeted therapies and nanomedicine. Accurins are polymeric nanoparticles that incorporate a therapeutic payload and are designed to have prolonged circulation within the bloodstream, enable targeting of the diseased tissue or cells, and provide for the controlled and timely release of the therapeutic payload. The four components include Targeting ligands, Stealth and protective layer, Controlled-release polymer matrix and Therapeutic payload. The Company focuses to use its medicinal nanoengineering platform to develop Accurins in several therapeutic areas, with an initial focus on the treatment of various types of cancer. In addition, the Company entered into collaboration agreements with several biopharmaceutical companies to develop and commercialize Accurins that are based on its collaborators��therapeutic payloads. The Company�� programs include BIND-014, solid tumor accurin and hematologic cancer accurin.

Advisors' Opinion:

• [By John Udovich]

  The biotech sector has been pretty exciting this year�with small cap biotech stocks Prana Biotechnology Limited (NASDAQ: PRAN) and TNI BioTech (OTCMKTS: TNIB) having recently produced noteworthy news for investors�while Acceleron Pharma, Inc (NASDAQ: XLRN), Ophthotech (NASDAQ: OPHT) and BIND Therapeutics (NASDAQ: BIND) have just�set term sheets for their upcoming IPOs. Just consider all of the following recent news:

• [By John Udovich]

  If you have not been watching the biotech sector lately, you should start paying attention as the sector along with small cap biotech stocks like Cell Therapeutics Inc (NASDAQ: CTIC), BIND Therapeutics Inc (NASDAQ: BIND) and TNI BioTech (OTCMKTS: TNIB) continue to produce a steady stream of good news for investors thanks to positive industry trends. Moreover, Ophthotech Corp (NASDAQ: OPHT), Foundation Medicine Inc (NASDAQ: FMI), Evoke Pharma and Fate Therapeutics Inc (NASDAQ: FATE) are this week's biotech IPOs that will no doubt be watched closely by Wall Street and industry observers in general. With that in mind, consider the following biotech news or recent articles about the industry and the small cap players in it:

• [By John Udovich]

  Yesterday, small cap biotech Acceleron Pharma Inc (NASDAQ: XLRN) rose 9.76%�plus shares are up 183.6% for retail investors since its September IPO, meaning its worth taking a closer look at the stock along with the performance of other biotech IPOs like BIND Therapeutics Inc (NASDAQ: BIND), Ophthotech Corp (NASDAQ: OPHT) and Foundation Medicine Inc (NASDAQ: FMI) which also debuted at the same time.

Top 5 Integrated Utility Companies To Buy For 2015: Joe's Jeans Inc.(JOEZ)

Joe?s Jeans Inc. designs, produces, and sells apparel and apparel-related products worldwide. Its product line comprises women?s and men?s denim jeans, pants, shirts, sweaters, jackets, and other apparel products under the Joe?s brand. The company also offers women?s handbags and clutches, shoes, belts, and leather goods under various license agreements. In addition, it provides children?s products consisting of denim bottoms, tops, T-shirts, and jackets for infants, toddlers, girls, and boys. The company sells its products to various retailers, including department stores, specialty stores, and distributors, as well as through its retail stores; and through the Internet site, joesjeans.com/shop. As of November 30, 2011, it operated 17 outlet stores and 5 full price retail stores. The company was formerly known as Innovo Group Inc. and changed its name to Joe?s Jeans Inc. in October 2007. Joe?s Jeans Inc. was founded in 1987 and is based in Commerce, California.

Advisors' Opinion:

• [By James E. Brumley]

  Considering Joe's Jeans Inc. (NASDAQ:JOEZ) is currently trading 22% below where it closed on Monday, it would understandably be easy to assume the company was a mess and the stock was best left avoided. Just because JOEZ is being punished for a bad quarter, however, doesn't mean the punishment fits the crime. For that matter, it's not entirely clear the stock deserves to be punished at all... making this week's big plunge a buying opportunity.

• [By Dan Caplinger]

  Joe's Jeans (NASDAQ: JOEZ  ) will release its quarterly report next Monday, and the tiny company is hoping to return to its profit-making ways after posting a loss in its fiscal first quarter. But, with a major transaction having taken place in the industry, Joe's will have to work hard in order to maintain its competitive position in high-end retail.